Drop-free approaches for cataract surgery
Neal H Shorstein1, William G Myers
1Departments of Ophthalmology and Quality, Shorstein - Kaiser Permanente, Oakland, California; Department of Ophthalmology, Myers - Northwestern University, Chicago, IL.
Current Opinion in Ophthalmology
|November 6, 2019
Summary
Surgeon-administered intraocular injections are replacing eye drops for cataract surgery prophylaxis. This method ensures accurate drug delivery, optimizing healing and reducing complications from patient-administered topical treatments.
Area of Science:
- Ophthalmology
- Surgical Innovation
- Pharmacology
Background:
- Traditional cataract surgery prophylaxis relied on patient-administered topical eye drops.
- Patient adherence and correct instillation technique can be challenging with topical drops.
- Topical drop use can lead to issues like corneal toxicity and inconsistent dosing.
Purpose of the Study:
- To review the evolving landscape of prophylaxis for adverse events after cataract surgery.
- To highlight the shift from topical eye drops to surgeon-administered intraoperative injections.
- To assess the benefits of assured drug delivery for optimizing healing and reducing complications.
Main Methods:
- Review of current trends and emerging techniques in cataract surgery prophylaxis.
- Analysis of the advantages of intraoperative drug delivery methods.
- Discussion of the development of periocular corticosteroid injection techniques.
Main Results:
- Increasing adoption of intracameral antibiotic injections by European and American surgeons.
- Development of periocular corticosteroid injection techniques for inflammation prophylaxis.
- Potential to achieve a "drop-free" cataract surgery experience when combined with intraoperative pharmacologic dilation.
Conclusions:
- Intraoperative injections provide reliable drug delivery for both patients and surgeons.
- This approach circumvents problems associated with patient adherence and topical drop instillation.
- Intraoperative injections promise improved outcomes and reduced adverse events compared to traditional methods.
Related Concept Videos
Angle Closure Glaucoma: Treatment
1.1K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.1K
Open Angle Glaucoma: Treatment
912
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
912


